Fundz

HealthEquity

Draper, Utah, United States · Employee Benefits, Finance, Financial Services

HealthEquity is a leading administrator of Health Savings Accounts (HSAs) and other consumer-directed benefits—FSA, HRA, COBRA, and Commuter. Benefits advisors, health plans, and retirement providers partner with us to help over 17 million members work toward long-term health and financial wellbeing. Visit HealthEquity.com to see our intuitive technology and remarkable service in action.

Key facts

Headquarters
Draper, Utah, United States
Employees
3,200
Industries
Employee Benefits, Finance, Financial Services
Status
Public (HQY)
Website
healthequity.co
LinkedIn
Company page

Recent activity at HealthEquity

  • : Healthequity, Inc. Announces Departure of Chief Commercial Officer
  • : SEC 8-K (5.02): The filing reports the departure of Michael Fiore, Chief Commercial Officer of HealthEquity, Inc., effective October 5, 2026. Mr. Fiore's responsibilities will be redistributed among other members of the management team. In return for executing a release of claims against the company, he will receive severance payments and benefits as outlined in his employment agreement. This change may indicate a shift in the company's strategic leadership structure and could impact future commercial initiatives.
  • : SEC 8-K (5.02): On September 24, 2026, HealthEquity, Inc. appointed Noémie Heuland as a new member of its Board of Directors, expanding the Board from ten to eleven members. Ms. Heuland, who is currently the Chief Financial Officer of Moody’s Corporation, will serve on the Audit and Risk Committee and the Cybersecurity and Technology Committee of the Board. This appointment reflects a strategic move to enhance the Board's expertise in financial oversight and technology, although there are no arrangements or understandings that influenced her appointment. Her compensation details were not fully reported, aside from an approximate amount of $146,519 paid by the company during the previous fiscal year.
  • : SEC 8-K (5.07): On June 25, 2026, Healthequity, Inc. conducted its 2026 Annual Meeting where stockholders voted on five proposals. As of the record date, May 6, 2026, there were 83,830,457 shares entitled to vote. The proposals included the election of ten directors to serve until the 2027 Annual Meeting, all of which were approved by the shareholders. This event is significant as it establishes the leadership for the company moving forward and reflects shareholder confidence in the current board members.
  • : SEC 8-K (5.02): On May 5, 2026, key executives including Scott Cutler (President and CEO) and others signed amendments to their employment agreements, enhancing severance payments. Mr. Cutler's amendment stipulates severance of 12 months base salary plus a target cash bonus, increasing to 150% of his target bonus if termination occurs within 18 months following a change in control. Other executives will receive their severance under similar terms. The amendments include conditions for the receipt of severance, such as executing a release of claims. Additionally, on March 25, 2026, vesting terms for equity awards were approved, allowing certain restricted stock units to fully vest under specific termination conditions prior to a change in control. This move aims to retain top talent and provide financial security during leadership transitions.
  • : Healthequity Announces Chief Technology Officer Departure and Interim Oversight Transition
  • : SEC 8-K (5.02): On April 6, 2026, HealthEquity, Inc. announced the termination of Eli Rosner, the Chief Technology Officer, without cause, effective April 17, 2026. Following his departure, Sunil Rajasekar, the Executive Vice President and Chief Product and Strategy Officer, will take over the responsibilities of overseeing the Company's technology organization. Mr. Rosner will receive severance payments in accordance with his previous agreement, contingent upon his compliance with certain release and restrictive covenants. This management change signals a strategic shift in the technological direction of HealthEquity, which may impact ongoing and future projects.
  • : SEC 8-K (5.02): On April 6, 2026, HealthEquity, Inc. announced the termination of Eli Rosner, the Chief Technology Officer, without cause, effective April 17, 2026. Sunil Rajasekar, who has been the Executive Vice President, Chief Product and Strategy Officer since January 2026, will take over oversight of the technology organization. Mr. Rosner will receive severance payments as per his employment agreement, which includes conditions related to the release of claims and compliance with restrictive covenants. This management change reflects a strategic shift in the Company's leadership amid ongoing developments in their technology operations.
  • : SEC 8-K (5.02):
  • : SEC 8-K (5.02): On March 26, 2026, HealthEquity, Inc. appointed William Gassen as a member of its Board of Directors, expanding the Board from nine to ten members. Mr. Gassen will also serve on the Audit and Risk Committee and the Talent, Compensation and Culture Committee. His appointment is significant as he is the CEO of Sanford Health, bringing valuable expertise to the Board. There was no prior arrangement regarding his appointment, which reflects the Company’s strategy to enhance its governance and oversight capabilities.

Leadership

  • Michael Fiore, Chief Commercial Officer
  • James Lucania, Chief Financial Officer
  • Scott Cutler, Chief Executive Officer
  • Sunil Seshadri, EVP & CSO
  • Sunil Rajasekar, Executive Vice President
  • Eli Rosner, Chief Technology Officer
  • Garett Kitch, Vice President
  • Mukund Ramachandran, Chief Marketing Officer

Verified email and direct lines for HealthEquity’s decision-makers are on Fundz. See plans — or book a 15-minute walkthrough.

Employee benefit plans

HealthEquity files 9 employee benefit plans with the U.S. Department of Labor, including a retirement plan. The next plan year renews in Dec 2026.

HealthEquity in the news

Companies similar to HealthEquity

About HealthEquity: questions and answers

What does HealthEquity do?

HealthEquity is a leading administrator of Health Savings Accounts (HSAs) and other consumer-directed benefits—FSA, HRA, COBRA, and Commuter. Benefits advisors, health plans, and retirement providers partner with us to help over 17 million members work toward long-term health and financial wellbeing. Visit HealthEquity.com to see our intuitive technology and remarkable service in action.

Where is HealthEquity headquartered?

HealthEquity is headquartered in Draper, Utah, United States.

How many employees does HealthEquity have?

HealthEquity has about 3,200 employees.

Who leads HealthEquity?

Scott Cutler is a Chief Executive Officer at HealthEquity.

What is the latest news on HealthEquity?

On Oct 09, 2026, Healthequity, Inc. Announces Departure of Chief Commercial Officer

Is HealthEquity a public company?

Yes. HealthEquity is publicly traded under the ticker HQY.

Source: Fundz records from SEC filings, press releases and company announcements. How Fundz measures data accuracy

Fundz watches HealthEquity across 18 signal types, from funding and M&A to exec moves and hiring.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.